Paper Details

  1. Home
  2. Paper Details

Intralesional measles, mumps, and rubella vaccine after failure of intralesional Candida antigen for the treatment of recalcitrant pediatric warts.

Author: HollandKristen E, LieglMelodee, PanAmy Y, PatelJay, UlschmidCaden M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This retrospective study investigated the efficacy of intralesional measles, mumps, and rubella vaccine for the treatment of pediatric warts in patients who failed to respond to intralesional Candida antigen. The study found that a significant proportion of patients experienced complete or partial resolution of their warts after receiving the vaccine, suggesting it may be a viable alternative treatment option for recalcitrant warts.
Paper Details　
Original Abstract of the Article :
Numerous studies have investigated the efficacy of intralesional immunotherapy for warts, but there are a lack of studies investigating the efficacy of alternative intralesional immunotherapies following failure of initial intralesional immunotherapy. In this retrospective study, we aimed to investi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/pde.15415

データ提供：米国国立医学図書館（NLM）

Treating Pediatric Warts: A New Oasis in the Desert of Skin Conditions

This retrospective study examines the efficacy of intralesional measles, mumps, and rubella (MMR) vaccine as an alternative immunotherapy for pediatric warts in patients who have not responded to intralesional Candida antigen. It's like exploring a new oasis in the desert of skin conditions, searching for alternative solutions to persistent and challenging dermatological problems.

A New Approach to Persistent Warts

The study found that intralesional MMR vaccine administration resulted in complete resolution of warts in 15.5% of patients, with varying degrees of improvement in others. It suggests that MMR vaccine might offer a potential therapeutic option for recalcitrant pediatric warts in patients who have not responded to conventional treatments. It's like discovering a new well of water in the desert, providing a fresh source of hope for those struggling with stubborn skin conditions.

Navigating the Shifting Sands of Skin Conditions

This research highlights the importance of exploring alternative treatment options for persistent pediatric warts, especially when conventional therapies fail. It underscores the need for ongoing research and innovation to find new and effective ways to address these challenging dermatological conditions. It's like navigating the shifting sands of skin conditions, constantly seeking new pathways and solutions to improve patient outcomes.

Dr.Camel's Conclusion

This study offers a glimmer of hope in the challenging landscape of pediatric warts. The findings suggest that intralesional MMR vaccine might represent a promising alternative treatment option for recalcitrant cases. As a seasoned explorer of the medical desert, I find this research to be a refreshing reminder that there are often hidden oases of hope waiting to be discovered in the pursuit of better treatments for challenging skin conditions.

Date :
  1. Date Completed 2023-11-17
  2. Date Revised 2023-11-17
Further Info :

Pubmed ID

37596908

DOI: Digital Object Identifier

10.1111/pde.15415

Related Literature

Article Analysis
・Effective treatment of rubella
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.